相似文献
1
Design, synthesis and activity evaluation of mannose-based DC-SIGN antagonists.
Mol Divers. 2011 May;15(2):347-60. doi: 10.1007/s11030-010-9285-y. Epub 2010 Nov 14.
2
Monovalent mannose-based DC-SIGN antagonists: targeting the hydrophobic groove of the receptor.
Eur J Med Chem. 2014 Mar 21;75:308-26. doi: 10.1016/j.ejmech.2014.01.047. Epub 2014 Jan 31.
3
New lipophilic glycomimetic DC-SIGN ligands: Stereoselective synthesis and SPR-based binding inhibition assays.
Bioorg Chem. 2021 Feb;107:104566. doi: 10.1016/j.bioorg.2020.104566. Epub 2020 Dec 19.
4
Facile access to pseudo-thio-1,2-dimannoside, a new glycomimetic DC-SIGN antagonist.
Bioorg Med Chem. 2017 Oct 1;25(19):5142-5147. doi: 10.1016/j.bmc.2017.03.046. Epub 2017 Mar 22.
5
Rational-Differential Design of Highly Specific Glycomimetic Ligands: Targeting DC-SIGN and Excluding Langerin Recognition.
ACS Chem Biol. 2018 Mar 16;13(3):600-608. doi: 10.1021/acschembio.7b00958. Epub 2018 Jan 8.
6
STD NMR and molecular modelling insights into interaction of novel mannose-based ligands with DC-SIGN.
Org Biomol Chem. 2016 Jan 21;14(3):862-75. doi: 10.1039/c5ob01916h. Epub 2015 Nov 18.
7
DC-SIGN antagonists, a potential new class of anti-infectives.
Curr Med Chem. 2012;19(7):992-1007. doi: 10.2174/092986712799320664.
8
Selective targeting of dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN) with mannose-based glycomimetics: synthesis and interaction studies of bis(benzylamide) derivatives of a pseudomannobioside.
Chemistry. 2013 Apr 8;19(15):4786-97. doi: 10.1002/chem.201202764. Epub 2013 Feb 18.
9
Polyvalent C-glycomimetics based on l-fucose or d-mannose as potent DC-SIGN antagonists.
Org Biomol Chem. 2017 May 10;15(18):3995-4004. doi: 10.1039/c7ob00322f.
10
Designing nanomolar antagonists of DC-SIGN-mediated HIV infection: ligand presentation using molecular rods.
Chem Commun (Camb). 2015 Mar 4;51(18):3816-9. doi: 10.1039/c4cc09709b.
引用本文的文献
1
Lewis-X-Containing Triterpenoid Saponins Inhibit DC-SIGN- and L-SIGN-Mediated Transfer of HIV-1 Infection.
Chemistry. 2025 Jun 6;31(32):e202500993. doi: 10.1002/chem.202500993. Epub 2025 May 6.
2
Recent Advances in Biomedical Applications of Mannans and Xylans.
Curr Drug Targets. 2024;25(4):261-277. doi: 10.2174/0113894501285058240203094846.
3
Drug-like Inhibitors of DC-SIGN Based on a Quinolone Scaffold.
ACS Med Chem Lett. 2022 May 10;13(6):935-942. doi: 10.1021/acsmedchemlett.2c00067. eCollection 2022 Jun 9.
4
Molecular Recognition in C-Type Lectins: The Cases of DC-SIGN, Langerin, MGL, and L-Sectin.
Chembiochem. 2020 Nov 2;21(21):2999-3025. doi: 10.1002/cbic.202000238. Epub 2020 Jul 2.
5
On-Chip Screening of a Glycomimetic Library with C-Type Lectins Reveals Structural Features Responsible for Preferential Binding of Dectin-2 over DC-SIGN/R and Langerin.
Chemistry. 2018 Sep 25;24(54):14448-14460. doi: 10.1002/chem.201802577. Epub 2018 Sep 3.
6
Comparative evaluation of several docking tools for docking small molecule ligands to DC-SIGN.
J Mol Model. 2015 Jun;21(6):164. doi: 10.1007/s00894-015-2713-2. Epub 2015 Jun 4.
7
Efficient synthesis of phenylene-ethynylene rods and their use as rigid spacers in divalent inhibitors.
Beilstein J Org Chem. 2013;9:215-22. doi: 10.3762/bjoc.9.25. Epub 2013 Jan 31.
本文引用的文献
1
A general glycomimetic strategy yields non-carbohydrate inhibitors of DC-SIGN.
Chem Commun (Camb). 2010 Sep 28;46(36):6747-9. doi: 10.1039/c0cc00830c. Epub 2010 Aug 18.
2
An assay for functional dendritic cell-specific ICAM-3-grabbing nonintegrin (DC-SIGN) inhibitors of human dendritic cell adhesion.
Anal Biochem. 2010 Nov 15;406(2):222-9. doi: 10.1016/j.ab.2010.07.018. Epub 2010 Jul 25.
3
C-type lectin DC-SIGN: an adhesion, signalling and antigen-uptake molecule that guides dendritic cells in immunity.
Cell Signal. 2010 Oct;22(10):1397-405. doi: 10.1016/j.cellsig.2010.03.018. Epub 2010 Apr 2.
4
Kinetic and thermodynamic properties of MAG antagonists.
Carbohydr Res. 2010 Jul 2;345(10):1348-59. doi: 10.1016/j.carres.2010.03.010. Epub 2010 Mar 16.
5
Low molecular weight antagonists of the myelin-associated glycoprotein: synthesis, docking, and biological evaluation.
J Med Chem. 2010 Feb 25;53(4):1597-615. doi: 10.1021/jm901517k.
6
Inhibition of DC-SIGN-mediated HIV infection by a linear trimannoside mimic in a tetravalent presentation.
ACS Chem Biol. 2010 Mar 19;5(3):301-12. doi: 10.1021/cb900216e.
7
Fragment-based development of triazole-substituted O-galactosyl aldoximes with fragment-induced affinity and selectivity for galectin-3.
Org Biomol Chem. 2009 Oct 7;7(19):3982-90. doi: 10.1039/b909091f. Epub 2009 Jul 20.
8
Pathogen recognition by DC-SIGN shapes adaptive immunity.
Future Microbiol. 2009 Sep;4(7):879-90. doi: 10.2217/fmb.09.51.
9
Carbohydrate-specific signaling through the DC-SIGN signalosome tailors immunity to Mycobacterium tuberculosis, HIV-1 and Helicobacter pylori.
Nat Immunol. 2009 Oct;10(10):1081-8. doi: 10.1038/ni.1778. Epub 2009 Aug 30.
10
Gold manno-glyconanoparticles: multivalent systems to block HIV-1 gp120 binding to the lectin DC-SIGN.
Chemistry. 2009 Sep 28;15(38):9874-88. doi: 10.1002/chem.200900923.
Zotero 插件